These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effectiveness of Corticosteroid Therapy for Acute Neurological Symptoms in Incontinentia Pigmenti. Tomotaki S; Shibasaki J; Yunoki Y; Kishigami M; Imagawa T; Aida N; Toyoshima K; Itani Y Pediatr Neurol; 2016 Mar; 56():55-58. PubMed ID: 26777982 [TBL] [Abstract][Full Text] [Related]
10. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Goldberg MF; Custis PH Ophthalmology; 1993 Nov; 100(11):1645-54. PubMed ID: 8233390 [TBL] [Abstract][Full Text] [Related]
11. Incontinentia pigmenti. B S G; Pai GS; Pai AH; Vinekar AS; Pai HS; Noronha T; Fernandes MS Kathmandu Univ Med J (KUMJ); 2013; 11(41):91-3. PubMed ID: 23774424 [TBL] [Abstract][Full Text] [Related]
12. A rare cause of neonatal seizure: incontinentia pigmenti. Türkmen M; Eliaçik K; Temoçin K; Savk E; Tosun A; Dikicioğlu E Turk J Pediatr; 2007; 49(3):327-30. PubMed ID: 17990592 [TBL] [Abstract][Full Text] [Related]
13. Therapy resistant neonatal seizures, linear vesicular rash, and unusually early neuroradiological changes: incontinentia pigmenti: a case report, literature review and insight into pathogenesis. Kaczala GW; Messer MA; Poskitt KJ; Prendiville JS; Gardiner J; Senger C Eur J Pediatr; 2008 Sep; 167(9):979-83. PubMed ID: 17938957 [TBL] [Abstract][Full Text] [Related]
14. A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension. Mizuno M; Aso K; Tsuzuki Y; Kitazawa T; Migita O; Hokuto I; Yamamoto H Eur J Med Genet; 2020 Mar; 63(3):103764. PubMed ID: 31518693 [TBL] [Abstract][Full Text] [Related]
15. Incontinentia pigmenti in an infant. Leung AK; Kao CP; Robson WL J Pediatr; 2006 Jul; 149(1):138. PubMed ID: 16860144 [No Abstract] [Full Text] [Related]